Open AccessSARS-Cov-2 Seroprevalence in a French Kidney Transplant Center Located Within a “High-risk” Zone
Author(s) -
Sophie Caillard,
Ilies Benotmane,
Céline Meidinger,
Vanessa Jegou,
Sandra Ludwiller,
Anne Rihon,
Audrey Desmarquets,
Lucille Steinmetz,
Murielle Morvan,
Karima Kedjam,
Amandine Bigot,
Danielle Carole Roy,
Dominique Schmitt,
David Marx,
Xavier Bassand,
Peggy Perrin,
Gabriela Gautier-Vargas,
Noëlle Cognard,
Jérôme Olagne,
Laura Braun,
Françoise Heibel,
Jonas Martzloff,
AnneMarie Moulin,
Samira FafiKremer
Publication year - 2021
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000003766
Subject(s) - seroprevalence , asymptomatic , medicine , outbreak , cohort , serology , covid-19 , transmission (telecommunications) , kidney transplantation , cohort study , virology , disease , transplantation , immunology , antibody , infectious disease (medical specialty) , electrical engineering , engineering
Data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence in kidney transplant recipients (KTRs) remain rare. We sought to shed further light on this issue by conducting a single-center study in a kidney transplant center located in one of the France's highest risk zone (Grand Est) for coronavirus disease 2019 (Covid-19) during the initial disease outbreak.